Compositions and methods for inhibiting expression of anti-apoptotic genes
The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of an anti-apoptotic gene, comprising an antisense strand having a nucleotide sequence which is less that 25 nucleotides in length and which is substantially complementary to at least a part of an apoptotic gene, such as a Bcl gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of an anti-apoptotic gene using the pharmaceutical composition; and methods for inhibiting the expression of an anti-apoptotic gene in a cell.
1. An isolated double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a human bcl-2 gene in a cell, wherein said dsRNA comprises at least two sequences that are complementary to each other and wherein a sense strand comprises a first sequence and an antisense strand comprises a second sequence comprising a region of complementarity which is substantially complementary to at least a part of a mRNA encoding bcl-2, and wherein said region of complementarity is less than 30 base pairs in length, and wherein said first sequence comprises SEQ ID NO:7 and said second sequence comprises SEQ ID NO:8.
2. A cell comprising the dsRNA of claim 1 .
3. A vector for inhibiting the expression of a bcl-2 gene in a cell, said vector comprising a regulatory sequence operably linked to a nucleotide sequence that encodes at least one strand of a dsRNA, wherein one of the strands of said dsRNA is substantially complementary to at least a part of a mRNA encoding bcl-2 and wherein said dsRNA is less than 30 base pairs in length, and wherein one strand of the dsRNA comprises SEQ ID NO:8.
4. A cell comprising the vector of claim 3 .
5. The dsRNA of claim 1 , wherein said region of complementarity is between 21 and 24 nucleotides in length.
6. The vector of claim 3 , wherein said dsRNA is between 21 and 24 basepairs in length.
7. A method for inhibiting expression of the bcl-2 gene in a cell, the method comprising
(a) introducing into the cell the double-stranded ribonucleic acid (dsRNA) of claim 1 ; and
(b) maintaining the cell produced in step (a) for a time sufficient to obtain degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell.